| (210) | Number of the EPO application | 21175525 |
| (220) | Filing date of the EPO application | 2015.12.03 |
| (80) | EPO patent specification publication (B) | EPB nr. 07/2025, 2025.02.12 |
| (110) | EPO patent number | 3925598 |
| (21) | Number of the application | e 2022 0843 |
| (71) | Name(s) of applicant(s), code of the country | Aragon Pharmaceuticals, Inc., US; |
| (72) | Name(s) of inventor(s), code of the country | VERRECK Geert, BE; |
| (73) | Name(s) of owner(s), code of the country | Aragon Pharmaceuticals, Inc., US; |
| (54) | Title of the invention | ANTICANCER COMPOSITIONS |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | A61K 9/00 (2006.01.01); A61K 9/14 (2006.01.01); A61K 9/20 (2006.01.01); A61K 31/4439 (2006.01.01); A61P 35/00 (2006.01.01); A61P 35/04 (2006.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2022.08.31 |
| (30) | Priority | 14196605, 2014.12.05, EP |